HCA HEALTHCARE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 297 USD | -4.51% |
|
-9.24% | +9.72% |
| Apr. 15 | Truist Securities Adjusts Price Target on HCA Healthcare to $375 From $345 | MT |
| Apr. 15 | Ondine Biomedical's Steriwave reduces SSI's by 32%, study shows | AN |
Chart calendar HCA Healthcare, Inc.
6a7440dcdb03fe31.L1K-OtQ4FBfJDTrZFdxj1gz3Pw77avYf1OCX_WSS_1M.cGLsc79hQWTwSHWhIboy5n2hEnesHbUpkK7WmQOihwZFHNJZmQ1lYpxqUQ~7a6535ef16af1b31e4027e7d835ce36d
Upcoming events on HCA Healthcare, Inc.
Past events on HCA Healthcare, Inc.
| 2024-03-13 | Ex-dividend day |
| 2024-03-12 10:00 am | Oppenheimer Healthcare MedTech & Services Conference |
| 2024-01-30 10:00 am | Q4 2023 Earnings Call |
| 2024-01-30 07:30 am | Q4 2023 Earnings Release |
| 2023-12-12 | Ex-dividend day |
| 2023-11-14 11:45 am | Wolfe Research Healthcare Conference |
| 2023-11-09 09:00 am | Investor Day |
| 2023-10-24 10:00 am | Q3 2023 Earnings Call |
| 2023-10-24 08:47 am | Q3 2023 Earnings Release |
| 2023-09-26 05:15 pm | Association of Healthcare Value Analysis Professionals Conference |
| 2023-09-13 | Ex-dividend day |
| 2023-09-12 09:30 am | Morgan Stanley Global Healthcare Conference |
| 2023-07-27 10:00 am | Q2 2023 Earnings Call |
| 2023-07-27 07:30 am | Q2 2023 Earnings Release |
| 2023-06-14 | Ex-dividend day |
| 2023-05-16 09:00 am | RBC Global Healthcare Conference |
| 2023-05-10 11:40 am | Bank of America Healthcare Conference |
| 2023-04-21 10:00 am | Q1 2023 Earnings Call |
| 2023-04-21 07:00 am | Q1 2023 Earnings Release |
| 2023-04-19 03:00 pm | Annual General Meeting |
Past dividends on HCA Healthcare, Inc.
| 2024-03-13 | Quarterly 0.66 USD |
| 2023-12-12 | Quarterly 0.6 USD |
| 2023-09-13 | Quarterly 0.6 USD |
| 2023-06-14 | Quarterly 0.6 USD |
| 2023-03-15 | Quarterly 0.6 USD |
| 2022-12-12 | Quarterly 0.56 USD |
| 2022-09-14 | Quarterly 0.56 USD |
| 2022-06-14 | Quarterly 0.56 USD |
| 2022-03-15 | Quarterly 0.56 USD |
| 2021-12-12 | Quarterly 0.48 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 51 336 51 170 0.32% | 51 533 51 214 0.62% | 58 752 59 072 -0.54% | 60 233 60 416 -0.3% | 64 968 64 138 1.29% | 69 121 |
|
EBITDA Million USD | Released Forecast Spread | 9 857 9 785 0.74% | 10 037 9 781 2.62% | 12 644 12 665 -0.17% | 12 067 12 069 -0.02% | 12 726 12 462 2.12% | 13 278 |
|
EBIT Million USD | Released Forecast Spread | 7 261 7 229 0.44% | 7 316 7 058 3.65% | 9 791 9 844 -0.54% | 9 098 9 080 0.2% | 9 649 9 379 2.88% | 10 032 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 244 5 098 2.86% | 5 430 5 220 4.02% | 9 833 9 364 5% | 8 580 7 304 17.46% | 7 706 7 440 3.57% | 8 002 |
|
Net income Million USD | Released Forecast Spread | 3 505 3 532 -0.76% | 3 754 3 733 0.57% | 6 956 6 462 7.65% | 5 643 4 997 12.93% | 5 242 5 042 3.97% | 5 412 |
|
EPS USD | Released Forecast Spread | 10,1 10,1 -0.59% | 10,9 10,7 2.04% | 21,2 20,1 5.41% | 19,2 16,9 13.2% | 19,0 18,2 4.22% | 20,6 |
| Announcement Date | 28/01/20 | 02/02/21 | 27/01/22 | 27/01/23 | 30/01/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15 064 15 408 -2.24% | 14 945 14 720 1.53% | 14 820 14 730 0.61% | 14 971 15 001 -0.2% | 15 497 15 630 -0.85% | 15 591 15 267 2.13% | 15 861 15 618 1.55% | 16 213 15 823 2.47% | 17 303 16 517 4.76% | 16 815 | 16 977 | 17 192 | 18 224 | 17 656 |
|
EBITDA Million USD | Released Forecast Spread | 3 149 3 210 -1.91% | 2 944 3 020 -2.53% | 3 042 2 804 8.48% | 2 902 2 816 3.05% | 3 179 3 176 0.09% | 3 172 2 888 9.83% | 3 056 3 027 0.96% | 2 880 2 925 -1.54% | 3 618 3 338 8.4% | 3 282 | 3 235 | 3 081 | 3 704 | 3 421 |
|
EBIT Million USD | Released Forecast Spread | 2 421 2 497 -3.06% | 2 212 2 279 -2.94% | 2 304 2 050 12.38% | 2 153 2 097 2.65% | 2 429 2 417 0.51% | 2 416 2 117 14.11% | 2 293 2 258 1.55% | 2 111 2 158 -2.19% | 2 829 2 558 10.58% | 2 477 | 2 427 | 2 283 | 2 867 | 2 589 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 586 2 127 21.58% | 1 814 1 948 -6.88% | 1 760 1 651 6.6% | 1 704 1 669 2.12% | 3 302 1 996 65.45% | 1 922 1 693 13.5% | 1 809 1 781 1.59% | 1 630 1 677 -2.79% | 2 345 2 087 12.38% | 1 972 | 1 918 | 1 762 | 2 380 | 2 079 |
|
Net income Million USD | Released Forecast Spread | 1 814 1 466 23.72% | 1 273 1 327 -4.06% | 1 155 1 109 4.15% | 1 134 1 145 -0.98% | 2 081 1 370 51.84% | 1 363 1 142 19.33% | 1 193 1 211 -1.45% | 1 079 1 123 -3.93% | 1 607 1 386 15.92% | 1 365 | 1 292 | 1 180 | 1 595 | 1 460 |
|
EPS USD | Released Forecast Spread | 5,75 4,58 25.66% | 4,14 4,28 -3.25% | 3,90 3,59 8.7% | 3,91 3,94 -0.74% | 7,28 4,80 51.75% | 4,85 3,98 21.74% | 4,29 4,27 0.5% | 3,91 4,02 -2.83% | 5,93 5,05 17.38% | 5,10 | 4,87 | 4,50 | 6,18 | 5,68 |
| Announcement Date | 27/01/22 | 22/04/22 | 22/07/22 | 21/10/22 | 27/01/23 | 21/04/23 | 27/07/23 | 24/10/23 | 30/01/24 | - | - | - | - | - |
| 2024-04-21 | R&G PHARMASTUDIES CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-21 | R&G PHARMASTUDIES CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-23 06:45 am | QUEST DIAGNOSTICS INCORPORATED: Q1 2024 Earnings Release |
| 2024-04-23 07:00 am | OPTION CARE HEALTH, INC.: Q1 2024 Earnings Release |
| 2024-04-23 | EUROFINS SCIENTIFIC SE: Q1 2024 Sales and Revenue Release - Trading Update |
| 2024-04-23 | CHEMED CORPORATION: Q1 2024 Earnings Release |
| 2024-04-23 | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
| 2024-04-24 02:00 am | ATTENDO AB: Q1 2024 Earnings Release |
| 2024-04-24 | ACCOLADE, INC.: Q4 2024 Earnings Release |
| 2024-04-24 | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
Past sector events for HCA Healthcare, Inc.
| 2024-04-17 | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q4 2023 Earnings Release |
| 2024-04-08 04:30 pm | SUMMERSET GROUP HOLDINGS LIMITED: Q1 2024 Sales and Revenue Release |
| 2024-04-02 | PT FAMON AWAL BROS SEDAYA TBK: Q4 2023 Earnings Release (Projected) |
| 2024-03-28 04:00 am | RHÖN-KLINIKUM AG: Q4 2023 Earnings Release |
| 2024-03-28 01:06 am | FUTURE CARE TRADING CO.: Q4 2023 Earnings Release |
| 2024-03-26 | DIAGNOSTICOS DA AMÉRICA S.A.: Q4 2023 Earnings Release |
| 2024-03-26 | JINXIN FERTILITY GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-03-25 | REDE D'OR SÃO LUIZ S.A.: Q4 2023 Earnings Release |
| 2024-03-22 07:00 am | DENTALCORP HOLDINGS LTD.: Q4 2023 Earnings Release |
| 2024-03-21 07:00 am | WELL HEALTH TECHNOLOGIES CORP.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HCA Stock
- Calendar HCA Healthcare, Inc.
